MTST (MetaStat) Float Percentage Of Total Shares Outstanding: 98.39% (As of Jun. 28, 2026)


What is MetaStat Float Percentage Of Total Shares Outstanding?

MetaStat MTST Float Percentage Of Total Shares Outstanding is 98.39% as of Jun. 28, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, MetaStat's float shares is 5.79 Mil. MetaStat's total shares outstanding is 5.88 Mil. MetaStat's float percentage of total shares outstanding is 98.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, MetaStat's Insider Ownership is 2.02%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, MetaStat's Institutional Ownership is 0.00%.

MetaStat Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

MetaStat's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.79/5.88
=98.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 98.39% mean?
MetaStat (MTST) has a Float Percentage Of Total Shares Outstanding of 98.39% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on MetaStat and its competitors.
Is MetaStat's Float Percentage Of Total Shares Outstanding too high?
MetaStat's current Float Percentage Of Total Shares Outstanding is 98.39%.
How does MetaStat's Float Percentage Of Total Shares Outstanding compare to OBMP and NSPX?
MetaStat's Float Percentage Of Total Shares Outstanding of 98.39% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on MetaStat and its competitors. MetaStat's current Float Percentage Of Total Shares Outstanding is 98.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current Float Percentage Of Total Shares Outstanding of 98.39%. The current Float Percentage Of Total Shares Outstanding is 98.39%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For MetaStat (MTST), the current Float Percentage Of Total Shares Outstanding is 98.39% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.